EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Dr. Lal PathLabs's enterprise value is ₹204,695 Mil.
Dr. Lal PathLabs's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹6,785 Mil. Therefore, Dr. Lal PathLabs's EV-to-EBITDA for today is 30.17.
The historical rank and industry rank for Dr. Lal PathLabs's EV-to-EBITDA or its related term are showing as below:
NSE:LALPATHLAB'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 19.51 Med: 31.04 Max: 54.05
Current: 30.17
During the past 13 years, the highest EV-to-EBITDA of Dr. Lal PathLabs was 54.05. The lowest was 19.51. And the median was 31.04.
NSE:LALPATHLAB's EV-to-EBITDA is ranked worse than 80.36% of 112
companies
in the Medical Diagnostics & Research industry
Industry Median: 16.545
vs NSE:LALPATHLAB: 30.17
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Dr. Lal PathLabs EV-to-EBITDA Historical Data
The historical data trend for Dr. Lal PathLabs's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dr. Lal PathLabs's EV-to-EBITDA
For the Diagnostics & Research subindustry, Dr. Lal PathLabs's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Lal PathLabs's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Dr. Lal PathLabs's EV-to-EBITDA falls into.
Dr. Lal PathLabs's current Enterprise Value is ₹204,695 Mil.
Dr. Lal PathLabs's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6,785 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Lal PathLabs (NSE:LALPATHLAB) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Dr. Lal PathLabs's PE Ratio for today is calculated as:
Dr. Lal PathLabs's share price for today is ₹2549.25.
Dr. Lal PathLabs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹42.980.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Dr. Lal PathLabs's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:LALPATHLAB has been successfully added to your 